Floatz logo

Therapeutic Asset Ratings

388 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
NON-REPLICATING RECOMBINANT SELF-COMPLEMENTARY (SC) ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9) VECTOR CONTAINING THE CDNA OF THE SURVIVAL OF MOTOR NEURON 2 (SMN2) GENE UNDER THE CONTROL OF THE HYBRID CYTOMEGALOVIRUS (CMV) ENHANCER/CHICKEN BETA-ACTIN PROMOTER (CBA)
Spinal Muscular Atrophy
Novartis PharmaceuticalsP4A (80)
oav101
Spinal Muscular Atrophy
Novartis PharmaceuticalsP4BBB (78)
Siponimod
Secondary Progressive Multiple Sclerosis
Novartis PharmaceuticalsP4BBB (75)
Degarelix
Prostatic Neoplasms
Novartis PharmaceuticalsP4BBB (72)
Blinatumomab
Philadelphia Chromosome-Positive
Novartis PharmaceuticalsP3BBB (72)
Cytosin-Arabinosid
BCR-ABL1 Fusion Protein Expression
Novartis PharmaceuticalsP3BBB (72)
(+)-VINCRISTINE
Adult Anaplastic Oligodendroglioma
Novartis PharmaceuticalsP2BBB (72)
VIPIVOTIDE TETRAXETAN
Oligometastatic Prostate Cancer (OMPC)
Novartis PharmaceuticalsP4BB (71)
Crizanlizumab
Sickle Cell Disease
Novartis PharmaceuticalsP4BB (70)
METHOTREXATE
BCR-ABL1 Fusion Protein Expression
Novartis PharmaceuticalsP3BB (70)
Opnurasib
Carcinoma, Non-Small Cell Lung
Novartis PharmaceuticalsP3BB (70)
(+)-VINCRISTINE
Anaplastic Astrocytoma
Novartis PharmaceuticalsP2/3BB (70)
gsk1120212
Anaplastic Oligodendroglioma
Novartis PharmaceuticalsP4BB (69)
Quadrivalent Inactivated Influenza Vaccine
Relapsing Multiple Sclerosis
Novartis PharmaceuticalsP4BB (69)
Cetuximab
Carcinoma, Non-Small-Cell Lung
Novartis PharmaceuticalsP3BB (68)
Cytosin-Arabinosid
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Novartis PharmaceuticalsP3BB (68)
METHOTREXATE
Philadelphia Positive Acute Lymphoblastic Leukemia
Novartis PharmaceuticalsP3BB (68)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Acute Lymphoblastic Leukemia
Novartis PharmaceuticalsP4BB (67)
Blinatumomab
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Novartis PharmaceuticalsP3BB (67)
DEXAMETHASONE
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Novartis PharmaceuticalsP3BB (67)
Everolimus
Renal Angiomyolipoma
Novartis PharmaceuticalsP4BB (66)
Zoladex
Prostatic Neoplasms
Novartis PharmaceuticalsP4BB (66)
Octreotide Pamoate
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Novartis PharmaceuticalsP3BB (66)
Dabrafenib
Anaplastic Oligodendroglioma
Novartis PharmaceuticalsP4BB (65)
Dabrafenib
Angiocentric Glioma
Novartis PharmaceuticalsP4BB (65)
Showing 1 to 25 of 388 assets
PreviousPage 1 of 16Next